Cefotaxime sodium and Cerebral haemorrhage - a phase IV clinical study of FDA data

Summary:

Cerebral haemorrhage is found among people who take Cefotaxime sodium, especially for people who are male, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Cefotaxime sodium and have Cerebral haemorrhage. It is created by eHealthMe based on reports of 2,199 people who have side effects when taking Cefotaxime sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

2,199 people reported to have side effects when taking Cefotaxime sodium.
Among them, 7 people (0.32%) have Cerebral haemorrhage.


What is Cefotaxime sodium?

Cefotaxime sodium has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,200 Cefotaxime sodium users for its effectiveness, alternative drugs and more.

What is Cerebral haemorrhage?

Cerebral haemorrhage (bleeding within the brain) is found to be associated with 1,906 drugs and 1,450 conditions by eHealthMe.

Number of Cefotaxime sodium and Cerebral haemorrhage reports submitted per year:

Could Cefotaxime sodium cause Cerebral haemorrhage?

Time on Cefotaxime sodium when people have Cerebral haemorrhage *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Cerebral haemorrhage when taking Cefotaxime sodium *:

  • female: 28.57 %
  • male: 71.43 %

Age of people who have Cerebral haemorrhage when taking Cefotaxime sodium *:

  • 0-1: 33.33 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 16.67 %
  • 60+: 16.67 %

Common drugs people take besides Cefotaxime sodium *:

  1. Vancomycin: 3 people, 42.86%
  2. Piperacillin: 2 people, 28.57%
  3. Atropine: 2 people, 28.57%
  4. Syntocinon: 2 people, 28.57%
  5. Furosemide: 2 people, 28.57%
  6. Heparin: 2 people, 28.57%
  7. Flumazenil: 1 person, 14.29%
  8. Gentamicin Sulfate: 1 person, 14.29%
  9. Gentamicin: 1 person, 14.29%
  10. Gabapentin: 1 person, 14.29%

Common side effects people have besides Cerebral haemorrhage *:

  1. Cerebral Hypoxia (not enough oxygen getting to the brain): 2 people, 28.57%
  2. Blood Culture Positive: 2 people, 28.57%
  3. Adrenal Haemorrhage (bleeding into the adrenal gland): 2 people, 28.57%
  4. Consciousness - Decreased: 2 people, 28.57%
  5. Apgar Score Low: 2 people, 28.57%
  6. Neonatal Asphyxia (a condition in which an extreme decrease in the concentration of oxygen in the body accompanied by an increase in the concentration of carbon dioxide in neonate): 2 people, 28.57%
  7. Polycythaemia (proportion of blood volume that is occupied by red blood cells increases): 2 people, 28.57%
  8. Pneumonia: 2 people, 28.57%
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 28.57%
  10. Confusion: 1 person, 14.29%

Common conditions people have *:

  1. Thrombocytopenia (decrease of platelets in blood): 1 person, 14.29%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 14.29%
  3. Respiratory Distress Syndrome (Rds) In Infants (respiratory disease of newborn babies, especially premature babies, characterized by distressful breathing, cyanosis, and the formation of a glassy membrane over the alveoli of the lungs): 1 person, 14.29%
  4. Pneumonia: 1 person, 14.29%
  5. Infection: 1 person, 14.29%
  6. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 14.29%
  7. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Cefotaxime sodium and have Cerebral haemorrhage?

Check whether Cerebral haemorrhage is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Cerebral haemorrhage and when was it recovered:

Expand to all the drugs that have ingredients of cefotaxime sodium:

Alternative drugs to, pros and cons of Cefotaxime sodium:

Common Cefotaxime sodium side effects:

Browse all side effects of Cefotaxime sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Cerebral haemorrhage treatments and more:

COVID vaccines that are related to Cerebral haemorrhage:

Common drugs associated with Cerebral haemorrhage:

All the drugs that are associated with Cerebral haemorrhage:

Common conditions associated with Cerebral haemorrhage:

All the conditions that are associated with Cerebral haemorrhage:

How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium (the active ingredients of Cefotaxime sodium) and Cefotaxime sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: